Literature DB >> 16442297

Mitral regurgitation progression following isolated coronary artery bypass surgery: frequency, risk factors, and potential prevention strategies.

Saida Zen Campwala1, Ramesh C Bansal, Nan Wang, Anees Razzouk, Ramdas G Pai.   

Abstract

BACKGROUND: Though de novo mitral regurgitation (MR) is frequently seen in patients who have undergone coronary artery bypass surgery (CABG), its incidence, predictors, and mechanisms are not known.
METHODS: Our surgical registry was screened for patients undergoing isolated CABG who had preoperative and postoperative resting echocardiograms performed at our institution with <or=2+ MR preoperatively. This yielded 438 patients. Progression to 3-4+ MR post-CABG was correlated with clinical, electrocardiographic, echocardiographic, and operative variables.
RESULTS: New 3-4+ MR developed in 11 (10%) of the 108 patients with no prior MR, 21 of the 180 (12%) patients with pre-CABG 1+ MR, and 37 of the 150 (25%) patients with pre-CABG 2+ MR. MR progression correlated with female gender (42% vs 27%, p=0.01), history of renal insufficiency (12% vs 5%, p=0.05), prior-CABG (30% vs 17%, p=0.01), lack of beta-blocker use (19% vs 35%, p=0.008), lower incidence of significant PDA stenosis grafted (88% vs 98%, p=0.003), lower preoperative LVEF (42+/-19% vs 50+/-17%, p=0.001), larger LV size (p=0.01), pre-CABG MR grade (p=0.0002), and pre-CABG presence of LBBB block (20% vs 4%, p<0.0001). Independent predictors of MR progression, pre-CABG, were female gender (p=0.002), history of renal insufficiency (p=0.05), lack of beta-blocker use (p=0.006), MR grade (p=0.02), and presence of LBBB (p=0.005).
CONCLUSION: Development of significant MR following isolated CABG is common and may be related to incomplete myocardium revascularization, especially in the PDA area and LV remodeling. Preoperative, beta-blocker use may be protective against its development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442297     DOI: 10.1016/j.ejcts.2005.12.007

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

1.  Mitral valve repair for ischemic mitral regurgitation: lessons from the Cardiothoracic Surgical Trials Network randomized study.

Authors:  Christos G Mihos; Orlando Santana
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

Review 2.  Surgical Treatment of Ischemic Mitral Regurgitation: Valve Repair Versus Replacement.

Authors:  Abhishek Sharma; Sahil Agrawal; Sunny Goel; Jeffrey S Borer
Journal:  Curr Cardiol Rep       Date:  2017-01       Impact factor: 2.931

3.  Outcomes and long-term quality of life of patients with severe left ventricular dysfunction who underwent coronary artery bypass surgery.

Authors:  Saeed Davoodi; Mehrdad Sheikhvatan; Abbasali Karimi; Seyed Hossein Ahmadi; Hamidreza Goodarzynejad; Mahmood Sheikh Fathollahi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

Review 4.  Surgical management of moderate ischemic mitral valve regurgitation: Where do we stand?

Authors:  Khalil Fattouch; Sebastiano Castrovinci; Giacomo Murana; Marco Moscarelli; Giuseppe Speziale
Journal:  World J Cardiol       Date:  2014-11-26

5.  Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience.

Authors:  Anthony W Castleberry; Judson B Williams; Mani A Daneshmand; Emily Honeycutt; Linda K Shaw; Zainab Samad; Renato D Lopes; John H Alexander; Joseph P Mathew; Eric J Velazquez; Carmelo A Milano; Peter K Smith
Journal:  Circulation       Date:  2014-04-17       Impact factor: 29.690

6.  Coronary revascularization alone or with mitral valve repair: outcomes in patients with moderate ischemic mitral regurgitation.

Authors:  Sorel Goland; Lawrence S C Czer; Robert J Siegel; Michele A DeRobertis; James Mirocha; Kaveh Zivari; Robert M Kass; Sharo Raissi; Gregory Fontana; Wen Cheng; Alfredo Trento
Journal:  Tex Heart Inst J       Date:  2009

7.  Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.

Authors:  Krzysztof Wrobel; Susanna R Stevens; Robert H Jones; Craig H Selzman; Andre Lamy; Thomas M Beaver; Ljubomir T Djokovic; Nan Wang; Eric J Velazquez; George Sopko; Irving L Kron; J Michael DiMaio; Robert E Michler; Kerry L Lee; Michael Yii; Chua Yeow Leng; Marian Zembala; Jean L Rouleau; Richard C Daly; Hussein R Al-Khalidi
Journal:  Circulation       Date:  2015-08-25       Impact factor: 29.690

Review 8.  Ischemic Mitral Regurgitation: A Multifaceted Syndrome with Evolving Therapies.

Authors:  Mattia Vinciguerra; Francesco Grigioni; Silvia Romiti; Giovanni Benfari; David Rose; Cristiano Spadaccio; Sara Cimino; Antonio De Bellis; Ernesto Greco
Journal:  Biomedicines       Date:  2021-04-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.